1. Home
  2. LODE vs ARCT Comparison

LODE vs ARCT Comparison

Compare LODE & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

N/A

Current Price

$3.23

Market Cap

225.3M

Sector

Industrials

ML Signal

N/A

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

N/A

Current Price

$8.89

Market Cap

189.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LODE
ARCT
Founded
1999
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.3M
189.9M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
LODE
ARCT
Price
$3.23
$8.89
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$4.00
$24.11
AVG Volume (30 Days)
965.5K
389.5K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
63.55
20.00
EPS
N/A
N/A
Revenue
$1,553,796.00
$82,031,000.00
Revenue This Year
$1,582.85
N/A
Revenue Next Year
$246.20
$12.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.24
$5.85
52 Week High
$4.80
$24.14

Technical Indicators

Market Signals
Indicator
LODE
ARCT
Relative Strength Index (RSI) 51.38 58.55
Support Level $3.02 $6.90
Resistance Level $3.28 $9.14
Average True Range (ATR) 0.13 0.39
MACD 0.01 -0.03
Stochastic Oscillator 56.94 55.96

Price Performance

Historical Comparison
LODE
ARCT

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: